US president-elect Donald Trump has revealed his nomination for FDA Commissioner is Johns Hopkins University surgeon and researcher Dr Martin A Makary. Widely regarded as one of the incoming president’s less controversial selections, the appointment also has potential implications for those working on solutions targeting aging and age-related diseases.

Makary is said to be supportive of Robert F Kennedy Jr, Trump’s nominee for Health Secretary, and his mission to “end the chronic disease epidemic” – a message that will resonate well in the aging field. In September, Makary joined Kennedy in a roundtable on health and nutrition, where he criticized the US government for not prioritizing chronic diseases and food industry reform, saying that the country has “the most overmedicated, sickest population in the world and no one is talking about root causes.”

https://longevity.technology/news/could-trumps-fda-pick-be-a-positive-for-longevity/